We can get vaccines to people faster: A supply chain management perspective
New insights into B cells and why humans can produce trillions of disease-fighting antibodies
1 February 2021As scientists turn their attention to COVID-19, other research is not getting done
1 February 2021We can get vaccines to people faster: A supply chain management perspective
Last year, when the number of COVID-19 cases and deaths continued to climb, we put our hopes on the development of vaccines. When the good news came about the efficacy of the Pfizer-BioNTech and Moderna vaccines in November—practically medical miracles developed in record time—we believed we could soon vaccinate our way out of this crisis, and reach the herd immunity needed to get life back to normal.
